SecBot SecBot
PRESS-RELEASE ·Filed Apr 30, 2026

IRTC

iRhythm
BULLISH
Impact 8/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

The strong beat and raised guidance signal accelerating volume adoption and operating leverage. Monitor upcoming 10-Q for cash flow trajectory and litigation expense trends; the stock may gap up on the guidance raise and margin inflection.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$120.80
T+0 close · Apr 30, 2026 · via day close
Latest settled
−2.84%
T+60 · $117.37
Vs SPY
−5.91%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $120.80entry
  2. T+1 · 7mo ago −1.34%α −1.00% · $119.18
  3. T+5 · 6mo ago +3.37%α +1.02% · $124.87
  4. T+20 · 6mo ago −9.63%α −14.91% · $109.17
  5. T+60 · 4mo ago −2.84%α −5.91% · $117.37
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

iRhythm reported Q1 2026 revenue of $199.4M (+25.7% YoY) and GAAP EPS of -$0.43, beating consensus estimates of $194.1M and -$0.64. The company raised full-year 2026 revenue guidance to $875M-$885M and adjusted EBITDA margin to 12-13%, driven by volume growth and margin expansion across cardiology and primary care channels.

Key Financial Metrics

EPS
−$0.43
est −$0.64 · +32.8%
Revenue
$199.4M
est $194.1M · +2.7% · +25.7% YoY
Rating
strong beat
Guidance
$875M-$885M
raised
Free Cash Flow
-$33.1M
Gross Margin
70.9%

Key Facts

  • Q1 2026 revenue $199.4M vs consensus $194.1M (+2.7% beat)
  • GAAP EPS -$0.43 vs consensus -$0.64 (32.8% beat on a loss basis)
  • Revenue grew 25.7% YoY from $158.7M
  • Gross margin expanded 210 bps to 70.9%
  • Net loss improved to $13.9M from $30.7M YoY
  • Adjusted EBITDA turned positive to $14.1M from -$2.6M YoY
  • Raised FY2026 revenue guidance to $875M-$885M (prior undisclosed)
  • Raised FY2026 adjusted EBITDA margin guidance to 12-13%
  • Unrestricted cash and marketable securities $549.6M

Financial Impact

Revenue beat by ~$5.3M; EPS beat by $0.21 vs consensus; guidance raised by undisclosed amount

revenuegross marginnet lossadjusted EBITDAguidance

Risk Factors

  • Patent litigation costs ($3.7M in Q1) remain an overhang
  • Still GAAP-unprofitable with net loss of $13.9M
  • Operating cash flow negative at -$26.2M in Q1

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3285439

Track record

31 reports on IRTC

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
  2. Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  4. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  5. Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  6. Nov 5, 202611d ago 8-K Mixed 6/10 No price data
  7. Nov 5, 202611d ago Press Release Bullish 6/10 Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
  8. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
  9. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
  10. Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026